Multi-Industry Comments on FDA's Tool for the Prioritization of Food Chemicals for Post-Market Assessment
In August 2025, ASTA signed onto comments written by the Food & Beverage Issue Alliance (FBIA) encouraging FDA to leverage a science-driven, iterative approach for the prioritization of chemicals for post-market assessments. The comments call for FDA to place greater weight on public health risk-related factors, differentiate prioritization and assessment frameworks between intentionally added substances and contaminants, and to enhance transparency and stakeholder engagement opportunities.
08/19/2025 at 12:00 am
0
Related Resources
ASTA Comments on FDA Request for Information on Gluten Labeling and Cross-Contact in Packaged Foods
In April 2026, ASTA submitted comments in response to the Food and Drug Administration's (FDA) request for information (RFI) on labeling and cross-contact of gluten in packaged foods, which specifically referenced ingredients that can be declared using collective terms, such as spices. ASTA's comments highlight that no spices inherently contain gluten, note that FDA should take a scientific, risk-based approach to unintended gluten presence, and express support for consistency with existing FDA requirements and harmonization with internal standards for gluten labeling.
Multi-Industry Letter to RFK Jr. Opposing Cuts to Foodborne Illness Surveillance Program Funding
In November 2025, ASTA signed a Safe Food Coalition letter requesting that Health and Human Services (HHS) Secretary Kennedy fully fund the Centers for Disease Control and Prevention (CDC)’s Foodborne Diseases Active Surveillance Network (FoodNet), the only active foodborne illness surveillance network in the U.S., in response to proposed cuts to the program. The letter was co-signed by both trade associations and public health organizations concerned with this reduction in capacity on active foodborne illness surveillance.